These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32272550)

  • 1. Antiviral Agents: Discovery to Resistance.
    Adamson CS
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32272550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial overview: antivirals and resistance: advances and challenges ahead.
    Menéndez-Arias L; Richman DD
    Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
    [No Abstract]   [Full Text] [Related]  

  • 3. Summary of presentations from the International Workshop on Antiviral Drug Resistance: Meeting the Global Challenge, 3-7 June 2014, Berlin, Germany.
    Parkin N
    Antivir Ther; 2014; 19(7):701-17. PubMed ID: 25431873
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral drugs and antiviral drug resistance.
    Coen DM; Whitley RJ
    Curr Opin Virol; 2011 Dec; 1(6):545-7. PubMed ID: 22440912
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance in viruses other than HIV.
    Griffiths PD
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S32-7. PubMed ID: 12044287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral resistance: déjà vu?
    Sataloff RT
    Ear Nose Throat J; 2006 Apr; 85(4):206-7. PubMed ID: 16696346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Panavir, as a broad spectrum antiviral agent].
    Galegov GA; Litvin AA
    Antibiot Khimioter; 2007; 52(9-10):45-9. PubMed ID: 20583470
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial overview: Engineering for viral resistance.
    von Brunn A
    Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral therapeutics: where we are and where we are going.
    Chemaly RF; Clark TW
    Curr Opin Infect Dis; 2018 Dec; 31(6):512-513. PubMed ID: 30325760
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral drug resistance: mechanisms and clinical implications.
    Strasfeld L; Chou S
    Infect Dis Clin North Am; 2010 Jun; 24(2):413-37. PubMed ID: 20466277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for non-HIV viral infections.
    Treat Guidel Med Lett; 2010 Oct; 8(98):71-82; quiz 2 p following 82. PubMed ID: 20864902
    [No Abstract]   [Full Text] [Related]  

  • 12. New antivirals and drug resistance.
    Colman PM
    Annu Rev Biochem; 2009; 78():95-118. PubMed ID: 19254207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18th International Conference on Antiviral Research. Antivirals.
    Kibble A
    IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomolecular Condensates as Novel Antiviral Targets.
    Martin EW; Iserman C; Olety B; Mitrea DM; Klein IA
    J Mol Biol; 2024 Feb; 436(4):168380. PubMed ID: 38061626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the editor: Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
    Ciancio BC; Nicoll A
    Euro Surveill; 2007 Jun; 12(6):E070628.4; author reply E070628.5. PubMed ID: 17868571
    [No Abstract]   [Full Text] [Related]  

  • 16. Antisense inhibition of virus infections.
    Kilkuskie RE; Field AK
    Adv Pharmacol; 1997; 40():437-83. PubMed ID: 9217933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2006 (1st edition).
    Field HJ; Hodge AV; Brancale A; Otto M; Sidwells R; Baba M
    Antivir Chem Chemother; 2006; 17(3):111-2. PubMed ID: 16956067
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral therapy: old and current issues.
    Antonelli G; Turriziani O
    Int J Antimicrob Agents; 2012 Aug; 40(2):95-102. PubMed ID: 22727532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The program of antiviral agents inhibits virus infection.
    Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
    Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The priorities for antiviral drug resistance surveillance and research.
    Pillay D
    J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i57-8. PubMed ID: 17656384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.